Detection and Recovery of Economic Losses in Sales Person Based Pharmaceutical Bussiness

Authors

  • Bhardwaj N Computer Engineering, Bharati Vidyapeeth Deemed University College of Engineering, Pune, India
  • Jaiswal S Computer Engineering, Bharati Vidyapeeth Deemed University College of Engineering, Pune, India
  • Singh A Computer Engineering, Bharati Vidyapeeth Deemed University College of Engineering, Pune, India
  • Nikam SB Computer Engineering, Bharati Vidyapeeth Deemed University College of Engineering, Pune, India

DOI:

https://doi.org/10.26438/ijcse/v7i6.188190

Keywords:

pharma industry, money flow, money, money loss, money recovery

Abstract

It will explore the current supply chain trend which is in the pharmaceutical industry. It’s important objective was to characterize the pharmaceutical industry and it will identify the proper supply chain practice. As we know that The pharmaceutical industry will not be renowned for its supply chain management abilities but on the other hand many other high publicized industries they do have profitably exploit their proper supply chain. It is a interesting topic for particular research. Let’s take a look . we are going to argue that an excellent supply chain is paramount to the pharmaceutical industry boom. This particular business objective of the pharma industry including there was a need so that to be ensure that we have the drugs are protected from adulteration and counterfeiting, remove and it will destroy in the safe and environmental friendly manner. We see that Clearly and they are not at all commonly use metrics so that it assess the major performance of a particular company or a particular supply chain.

References

[1]. Abbott Laboratories. 1994-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/dRqWm.45Sx.htm, accessed March, 2010.

[2]. AstraZeneca International. 1999-2004. Annual Reports. http://www.astrazeneca.com/investors/annual-reports/, accessed April, 2010.

[3]. Bausch & Lomb Inc. 1994-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=10427&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2010.

[4]. Bowe, Christopher, and Demetri Sevastopulo. 2004. “Senators unite on bill for cheaper medicines.” Financial Times (UK edition). April 22: p. 8

[5]. Bowe, Christopher. 2004b. “States warm to reimport of drugs in US.” Financial Times (UK edition). August 23: p. 6

[6].Bristol-Myers Squibb Co. 1994-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=14272&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2010.

[7]. Chiron Corp. 1995-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=706539&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2010.

[8]. Cytogen Corp. 1995-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=725058&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2.

Downloads

Published

2019-06-30
CITATION
DOI: 10.26438/ijcse/v7i6.188190
Published: 2019-06-30

How to Cite

[1]
N. Bhardwaj, S. Jaiswal, A. Singh, and S. Nikam, “Detection and Recovery of Economic Losses in Sales Person Based Pharmaceutical Bussiness”, Int. J. Comp. Sci. Eng., vol. 7, no. 6, pp. 188–190, Jun. 2019.

Issue

Vol. 7 No. 6 (2019): IJCSE June Edition

Section

Review Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit and that in the event of reuse or distribution, the terms of this license are made clear.